PYC pyc therapeutics limited

1.19%

$1.28

You are no doubt right. But are they the best to take PYC...

First 10 Last

Share
Profile

Follow
SoT

858 Posts.

107

14/03/17

10:24

Post #: 23322291
Share

Originally posted by Heskumdai ↑

I'm a believer in the power of collaboration and like this approach, so quick Q for you SoT: Who do you think built these relationships and put these collaborations in place? My thoughts would be Watt and Hopkins - rather than the board per se. IF that is the case, then how robust are they without those two - although clearly Watt still has some involvement.

As to the PC for Dummies notion, sure the goal is to produce an amazing data pack and get millions in backing. Hopefully they will, but if they've hollowed out the science dept then who's going to lead it in the next stage? Maybe they pick someone up with their millions..?..but prima facie, without lead scientists and a CEO it feels like a shell ready to offload. Personally, I'd rather they develop the science further and improve the value proposition as that's where the value may be, but that also depends on timing to reach such inflextion points. Clearly it's all spec as we get little information from the Chairwoman, whose first promise to shareholders was to improve communications, but it's a slow game, so patience is a prerequisite. Unfortunately that doesn't always marry up with wanting to get a decent return on investment over a reasonable timeframe.

Expand

You are no doubt right. But are they the best to take PYC forward. I spoke to Hockings after RH went, and without divulging market sensitive info, he impressed me with his focus on what needed to be done and who was up to the job. I'm sitting tight.

Last edited by SoT: 14/03/17

PYC Price at posting: 3.3¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 10 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.28		Change 0.015(1.19%)		Mkt cap ! $746.5M

Open	High	Low	Value	Volume
$1.27	$1.28	$1.27	$194.9K	153.6K

Buyers (Bids)

No.	Vol.	Price($)
3	23982	$1.27

Sellers (Offers)

Price($)	Vol.	No.
$1.28	17208	6

View Market Depth

No.	Vol.	Price($)
3	23982	1.265
2	15414	1.260
1	12000	1.255
3	3414	1.250
1	7161	1.230

Price($)	Vol.	No.
1.280	17208	6
1.285	65010	4
1.290	25001	2
1.295	24500	1
1.300	79366	6

Last trade - 12.37pm 27/06/2025 (20 minute delay)

PYC (ASX) Chart

You are no doubt right. But are they the best to take PYC...

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

You are no doubt right. But are they the best to take PYC...

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News